Popular Articles

Washington D.C., Officials Urge Lawmakers To Block House Amendment That Would Impact Local Needle Exchange Programs
This week Del. Eleanor Holmes Norton (D-D.C.) and other Washington, D.C., officials "were racing to persuade congressional leaders to erase a House amendment that would essentially reinstate" a ban on using the district"s tax dollars to fund needle exchange programs, the Washington Post reports. A House bill including an amendment addressing needle exchange approved last week, which gives the district its federal appropriation for fiscal year 2010, "would prohibit the city from providing money to any needle exchange program that operates within 1,000 feet of virtually any location where children gather," according to the Post. Norton said, "It essentially wipes out the program," adding that she is calling on other lawmakers to pay close attention to any similar language in the Senate"s version of the bill, which is still in committee. According to the Post, "If the Senate does not include a similar amendment in its version of the bill, members would iron out their differences in a conference committee after Congress returns from its August recess. That"s where [district] officials and AIDS activists hope to kill the amendment" (Fears, 7/31).

WHO, Wyeth Launch Trial In Africa To Test New River Blindness Drug
The WHO on Wednesday announced plans for a clinical trial to test a new drug that "could halve the treatment period for river blindness [or onchocerciasis], a disease that threatens 100 million people mostly in Africa," AFP/Dow Jones Newswires/CNN Money reports (7/1). "This is a devastating illness that has plagued 30 African countries for centuries, in particular the populations in the most remote areas "beyond the end of the road,"" Uche Amazigo, director of the African Programme for Onchocerciasis Control (APOC), said (ANI/Thaindian.com, 7/1).
News of the day
Thirteen Single-Payer Activists Settle Their Cases After Disrupting Hearing
Thirteen people charged with "disruption of Congress" for standing and shouting pro-single-payer system slogans during a health care reform committee hearing settled their cases, The Great Falls (Mont.) Tribune reports.
Sexual Health

IBD Patient Launches iPhone Application To Help Doctors Treat Crohn's And Ulcerative Colitis

WellApps, Inc. launched an iPhone application to help people with (IBD) Crohn"s and Ulcerative Colitis provide accurate symptom data to their doctors for optimal treatment. The application, called GI Monitor , was developed by an 18-year Crohn"s patient after a recent flare up of his condition. Inspired by a long battle with Crohn"s disease, 34-year old Brett Shamosh, a Digital Media Executive from Bergen County, NJ, decided to use technology to help fellow IBD patients. After a recent Crohn"s flare up, Mr. Shamosh visited New York digestive disease specialist, Bruce Yaffe, M. D., for treatment. During his visits, Mr. Shamosh worked with Dr. Yaffe to understand what information helped him make treatment decisions. Says Mr. Shamosh, "The idea is not to replace a doctor"s diagnosis, but rather to help the doctor make better informed decisions. With so much going on in my life, it is difficult to recall exactly how I was feeling at a particular time and provide my doctor with accurate data about my symptoms. This is the problem I was trying to solve." GI Monitor allows a patient to easily log the frequency of bowel movements, consistency and blood level of stool, and pain/stress levels. In addition, the patient can keep a record of medications and dosages prescribed. All of this information is kept in detailed logs on the patient"s iPhone and is calculated into "My Status," which reveals how the patient is feeling on a simple scale of 1-10. Reports from any date range can be emailed directly to a doctor, or any concerned mother, right from the patient"s iPhone with the click of a button. The application is currently available in iTunes for $4.99 and will be released for BlackBerry devices soon. WellApps, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):